Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,444
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP
for
Congenital Erythropoietic Porphyria (CEP)
Location: Cleveland OH
Sponsor: Atlas Molecular Pharma
Sex: All
Age: 18+
Code: NCT07024316
Phase 1, Phase 2, Recruiting
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Cleveland OH, Kettering OH, Indianapolis IN,
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
for
Esophageal Cancer, Gastric Cancer (GC),
Location: Cleveland OH, Kettering OH, Indianapolis IN,
Sponsor: SOFIE
Sex: All
Age: 18+
Code: NCT07217704
Phase 3, Recruiting
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
for
Advanced Solid Tumors
Location: Cleveland OH, St Louis MO, Rochester MN,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT06973564
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Fluid Guided Heart Failure Treatment at the Cleveland Clinic
for
Heart Failure
Location: Cleveland OH
Sponsor: Bodyport Inc.
Sex: All
Age: 21+
Code: NCT07205120
Recruiting
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
for
Post Operative Pain, Spinal Surgery
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18 - 70+
Code: NCT07222072
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)